(VIANEWS) – RYANAIR HOLD. PLC (RYA.IR), GAMING INNOVATION (GIG.OL), MOWI (MOWI.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. RYANAIR HOLD. PLC (RYA.IR)
38.7% sales growth and 23.49% return on equity
Ryanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Italy, Spain, Germany, and other European countries. It is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services; in-flight sale of beverages, food, duty-free, and merchandise; and marketing of car hire and accommodation services, and travel insurance through its website and mobile app. In addition, the company offers aircraft and passenger handling, ticketing, and maintenance and repair services; and markets car parking, fast-track, airport transfers, attractions, and activities on its website and mobile app, as well as sells gift vouchers. As of June 30, 2022, it had a principal fleet of approximately 483 Boeing 737 aircrafts and 29 Airbus A320 aircrafts; and offered approximately 3,000 short-haul flights per day serving approximately 225 airports. Ryanair Holdings plc was founded in 1985 and is headquartered in Swords, Ireland.
Earnings Per Share
As for profitability, RYANAIR HOLD. PLC has a trailing twelve months EPS of €1.15.
PE Ratio
RYANAIR HOLD. PLC has a trailing twelve months price to earnings ratio of 14.66. Meaning, the purchaser of the share is investing €14.66 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.49%.
Volume
Today’s last reported volume for RYANAIR HOLD. PLC is 81093 which is 95.61% below its average volume of 1850060.
More news about RYANAIR HOLD. PLC.
2. GAMING INNOVATION (GIG.OL)
30.1% sales growth and 17.73% return on equity
Gaming Innovation Group Inc., an iGaming technology company, together with its subsidiaries, provides solutions, products, and services to iGaming operators in Nordic countries, other European countries, and internationally. It operates through two segments, Platform Offering Front-End Services (Platform), and Affiliate Marketing (Media). The company offers media services, such as operating various content rich websites, which empower potential players and connect them with online casino or sports betting sites; and platform services, including igaming platform solutions and services to operators and their customers, as well as undertakes land-based operators online through its omnichannel solution, which brings together the offline and online worlds through a shared loyalty system and wallets. It also provides Sportsbook, a sports betting omnichannel solution that offers a various digital content and sports events to players. In addition, the company offers managed service; omnichannel solutions; Data platform to enhance BI and make business decisions; Logic, a real-time rules engine that creates actionable business rules; marketing compliance solution; and Frontend solution. Gaming Innovation Group Inc. was founded in 2012 and is headquartered in St. Julian's, Malta.
Earnings Per Share
As for profitability, GAMING INNOVATION has a trailing twelve months EPS of kr0.85.
PE Ratio
GAMING INNOVATION has a trailing twelve months price to earnings ratio of 30.35. Meaning, the purchaser of the share is investing kr30.35 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.73%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
GAMING INNOVATION’s EBITDA is 36.91.
Sales Growth
GAMING INNOVATION’s sales growth for the next quarter is 30.1%.
More news about GAMING INNOVATION.
3. MOWI (MOWI.OL)
19.9% sales growth and 24.25% return on equity
Mowi ASA, a seafood company, produces and supplies farmed salmon products worldwide. It operates through three segments: Feed, Farming, and Sales and Marketing. The company is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. It offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. The company also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. It offers its products under the Mowi, Mowi Salmon, Donegal Silver, Admiral's, Pieters, Laschinger, Kritsen, Ducktrap River, Harbour Salmon Co., Rebel Fish, Supreme Salmon, Olav's, Northern Harvest, and Mowi Nutrition brand names. The company was formerly known as Marine Harvest ASA and changed its name to Mowi ASA in December 2018. Mowi ASA was founded in 1964 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, MOWI has a trailing twelve months EPS of kr19.64.
PE Ratio
MOWI has a trailing twelve months price to earnings ratio of 9.66. Meaning, the purchaser of the share is investing kr9.66 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.25%.
More news about MOWI.
4. ROBERTET (RBT.PA)
14.1% sales growth and 15.94% return on equity
Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in three segments: Raw materials, Fragrances, and Flavors. It also produces organic essential oils and active ingredients. The company operates in North America, Europe, the Asia Pacific, South America, Caribbean, Africa, and the Middle East. Robertet SA was founded in 1850 and is headquartered in Grasse, France.
Earnings Per Share
As for profitability, ROBERTET has a trailing twelve months EPS of €36.38.
PE Ratio
ROBERTET has a trailing twelve months price to earnings ratio of 23.36. Meaning, the purchaser of the share is investing €23.36 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.94%.
More news about ROBERTET.
5. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 22.97% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, obesity, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr1.79.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 21.51. Meaning, the purchaser of the share is investing kr21.51 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Sales Growth
NAVAMEDIC’s sales growth is 93.3% for the current quarter and 9.6% for the next.
Moving Average
NAVAMEDIC’s worth is under its 50-day moving average of kr38.93 and higher than its 200-day moving average of kr35.04.
Revenue Growth
Year-on-year quarterly revenue growth grew by 93.3%, now sitting on 440.93M for the twelve trailing months.
More news about NAVAMEDIC.
